MarketWatch.com - Top Stories

Moderna’s stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

Feb 27, 2025 - 17:11
 0
Moderna’s stock stumbles on report HHS is reviewing a $590 million bird-flu-vaccine award
The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.
Read More

Tags:

Previous Article

Amazon’s new Alexa+ may be its last, best chance to catch up in AI—and show the ...

Next Article

FirstEnergy Corp. (FE) Q4 2024 Earnings Conference Call Transcript

Related Posts

Hormel’s stock boosted by revenue beat, though challenges lie ahead with turkeys and nuts

Hormel’s stock boosted by revenue beat, though challeng...

Feb 27, 2025  0

Celsius wants to sell more energy drinks to women. Wall Street likes the move.

Celsius wants to sell more energy drinks to women. Wall...

Feb 21, 2025  0

Trump would be smart to pick this ‘battle-tested’ market expert to lead the Fed

Trump would be smart to pick this ‘battle-tested’ marke...

Feb 11, 2025  0